{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/allergic-rhinitis/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"5bd413c7-0398-5b71-acad-a5699c7c703b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 16435809-7c9b-4f21-a134-59e1be944151 --><h2>What else might it be?</h2><!-- end field 16435809-7c9b-4f21-a134-59e1be944151 -->","summary":"","htmlStringContent":"<!-- begin item cf21b208-0266-43b8-ba44-dbdb74213787 --><!-- begin field 2d75fefe-6ea9-43e0-8ef7-f7e3792acd83 --><p><strong>Alternative causes for rhinitis may include:</strong></p><ul><li><strong>Infective rhinitis</strong><ul><li>There is an acute onset of symptoms of one week or less, with typical features of an associated viral upper respiratory tract infection, such as cough, fever, or lymphadenopathy. If nasal discharge is clear, infection is less likely. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/common-cold/\">Common cold</a> for more information.</li></ul></li><li><strong>Non-allergic rhinitis</strong><ul><li>Autonomic or irritant rhinitis<ul><li>Symptoms typically follow a known physical exposure (changes in temperature or humidity, or with exercise) or chemical irritant exposure (volatile chemicals such as perfumes, tobacco smoke, and odours). These triggers cause nasal airway hyper-reactivity through a non-IgE mediated pathway.</li></ul></li><li>Drugs<ul><li>A number of drugs may cause or aggravate rhinitis symptoms, such as alpha-blockers, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, chlorpromazine, aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and cocaine.</li><li>Rebound symptoms and a paradoxical increase in nasal congestion may occur when stopping prolonged treatment with intranasal decongestants due to rebound vasodilatation (so-called 'rhinitis medicamentosa'). See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/allergic-rhinitis/prescribing-information/intranasal-decongestants/\">Intranasal decongestants</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/allergic-rhinitis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li>Endocrine<ul><li>Hormonal rhinitis should be considered when symptoms coincide with pregnancy, starting the oral contraceptive pill, hormone replacement therapy (HRT), or hypothyroidism. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> for more information.</li></ul></li><li>Food and drink<ul><li>Alcohol, sulphites, and spicy foods may cause rhinorrhoea and facial flushing.</li></ul></li><li>Non-allergic rhinitis with eosinophilia syndrome (NARES)<ul><li>This rare condition is a diagnosis of exclusion characterized by nasal eosinophils in people with perennial symptoms, and occasionally reduced sense of smell.</li><li>50% of people develop aspirin-sensitive disease with asthma and nasal polyposis later in life.</li></ul></li><li>Systemic<ul><li>May be caused by primary defects in mucus production (for example, cystic fibrosis), primary ciliary dyskinesia (Kartagener syndrome), and granulomatous disease (for example, Wegener's granulomatosis and sarcoidosis).</li></ul></li><li>Structural<ul><li>Typically caused by deviated nasal septum, nasal polyps, hypertrophic turbinates, adenoidal hypertrophy, foreign body, or cerebrospinal fluid (CSF) leak (rare), for example.</li><li>Sinonasal tumour (rare) should be excluded if there are unilateral symptoms, recurrent bloody nasal discharge or nosebleeds, nasal pain, anosmia, or visual disturbance. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/epistaxis-nosebleeds/\">Epistaxis (nosebleeds)</a> for more information.</li></ul></li></ul></li></ul><!-- end field 2d75fefe-6ea9-43e0-8ef7-f7e3792acd83 --><!-- end item cf21b208-0266-43b8-ba44-dbdb74213787 -->","topic":{"id":"e84371ef-9d30-56df-8358-1520fb2c324f","topicId":"0473d89c-2999-40d1-911f-d265b4bd3942","topicName":"Allergic rhinitis","slug":"allergic-rhinitis","lastRevised":"Last revised in September 2018","chapters":[{"id":"5fa28a05-233b-5de6-aee8-ea0327f3c7d6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ea1f0c07-a5f8-599b-9b96-71ef8590b2a6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"99b142c6-9593-51c7-9c86-7c8a537a3b8c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"67cd9666-b198-574f-9fbf-cd740a7d8c3e","slug":"changes","fullItemName":"Changes"},{"id":"7d544db5-f3b7-5709-a2ae-076455d76d20","slug":"update","fullItemName":"Update"}]},{"id":"392391e3-b09a-5cab-ae2a-040eb039abd9","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"292568d8-a1f5-5b8f-a13d-f3c014fa8e95","slug":"goals","fullItemName":"Goals"},{"id":"2f7129b7-e08b-5e5f-997c-4b661ce0a778","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8062582a-18e3-58d5-a8cb-f9689e259444","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1e562233-ae40-5755-abc7-71551f4cea02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ccab909c-169d-52aa-ac0a-9d425f89a99c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37d61d5d-e2f1-58ef-9c6a-27c4011784f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84432cb8-00ce-599e-9e05-3493755dacd6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f59296af-8e0a-509d-b8f3-692efd2bdb92","slug":"definition","fullItemName":"Definition"},{"id":"37020833-afb2-529a-975a-1f1a7a5db2ef","slug":"causes","fullItemName":"Causes"},{"id":"962f75f0-d73d-5c7c-aaf4-d08fc672e6be","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ab993d04-4c7b-59cd-9e56-2e0ef7fdc9db","slug":"complications","fullItemName":"Complications"},{"id":"68b348fd-2864-5da4-8687-6d8c25004f1b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"80c9e7d3-3315-55b9-98fb-2261b95a1b5c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"3cc3ef09-2238-5504-8781-48914ad6a4c9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"5a3f0e38-3f88-5049-beaa-f4cb26499dc6","slug":"assessment","fullItemName":"Assessment"},{"id":"5bd413c7-0398-5b71-acad-a5699c7c703b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9b8b1dfa-dfda-5292-a329-64d2c435a006","fullItemName":"Management","slug":"management","subChapters":[{"id":"a132cc60-bb1b-5679-8eda-db080a1e772a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"760f3c4d-0984-5865-acbe-65d470f66518","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a47a2aa5-0821-5bf5-987b-2397ac2c982f","slug":"intranasal-antihistamines","fullItemName":"Intranasal antihistamines"},{"id":"449809a3-a714-573e-a21f-8e4295eb984e","slug":"oral-antihistamines","fullItemName":"Oral antihistamines"},{"id":"5507fb81-aa18-5a21-b619-8db3c3c78e80","slug":"intranasal-cromones","fullItemName":"Intranasal cromones"},{"id":"5102b868-dccf-58c1-b6c7-3a59a24c6602","slug":"intranasal-decongestants","fullItemName":"Intranasal decongestants"},{"id":"623ba003-b473-5be2-bc25-e438f1500f7c","slug":"intranasal-anticholinergics","fullItemName":"Intranasal anticholinergics"},{"id":"c871daa0-d649-59f1-b13c-79ab64e7083e","slug":"oral-leukotriene-receptor-antagonists","fullItemName":"Oral leukotriene receptor antagonists"}]},{"id":"f3877d58-da5a-5655-8752-49e87f3a410b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"87371e7f-8741-54ef-9af6-339f8f0b9285","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"318f5be9-46cf-5fb9-b28c-7ebb4a901904","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49c3da95-9d4f-5a93-a7ca-e71965fcb981","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"33a2085c-95d6-5004-8f1f-50a08684c638","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b1a0d4a-fd5e-5b81-9293-5b2f004871cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"735b627c-7d7e-58b8-8196-b4972220342b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"92889a85-b6e7-58f3-9f09-eae6ca76386c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"80c9e7d3-3315-55b9-98fb-2261b95a1b5c","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"d59f611f-219c-5486-860e-a9a98ecd3e45","slug":"basis-for-recommendation-e60","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 902859f5-258d-44b6-8508-24052b9d74dc --><h3>Basis for recommendation</h3><!-- end field 902859f5-258d-44b6-8508-24052b9d74dc -->","summary":null,"htmlStringContent":"<!-- begin item e603f4ae-9164-4ee5-941d-c5c0564b0bc5 --><!-- begin field 5b2977a6-dab7-43eb-80b7-fb5ce59741cf --><p>The information on the differential diagnoses of allergic rhinitis is based on the 2008 Allergic Rhinitis and its Impact on Asthma (ARIA) international guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">ARIA, 2008</a>], expert opinion in the British Society of Allergy and Clinical Immunology guideline <em>BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Scadding, 2017</a>], a UK expert consensus statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Lipworth, 2017</a>], the European Academy of Allergy and Clinical Immunology position paper <em>Paediatric rhinitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Roberts, 2013</a>], and expert opinion in review articles on allergic rhinitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Quillen and Feller, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Saleh, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Barr, 2014</a>].</p><!-- end field 5b2977a6-dab7-43eb-80b7-fb5ce59741cf --><!-- end item e603f4ae-9164-4ee5-941d-c5c0564b0bc5 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}